AKT1 and acute lymphoblastic leukemia: Activation of the phosphatidylinositol-3-kinase (PI3K) pathway including AKT is associated with poor prognosis and drug resistance in pediatric pre-B ALL, as well as decreased chemotherapy-driven apoptosis in vitro [12].